• RESP® Platform
    • Biosensor
    • Watch
  • Solutions
    • For Healthcare
    • For Clinical Trials
    • For Academic Research
  • Therapeutic Areas
    • Asthma
    • Bronchiectasis
    • Chronic Cough
    • COPD
    • Pulmonary Fibrosis
  • Resources
    • About Strados Labs
    • News
    • Insights
    • Publications
  • Contact
Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant

Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant

by Shane Krauss | Mar 19, 2024 | Blog, Blog - Clinical Trial Focus

In November 2023, Merck’s chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough...

Recent Posts

  • Cough Intensity: A Novel Measure of Cough Burden
  • Data Processing Architectures for Cough Monitoring: The Case for Cloud Processing
  • Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis
  • Strados Labs Accelerates Research into Continuous Lung Sound Monitoring in 2025
  • From Stethoscope to Sensor: How We Developed a Lung Acoustics Wearable
Strados

Making Every Breath Count®

Offices
Philadelphia, PA
Atlanta, GA

Sitemap

  • About Strados
  • Support
  • Contact
  • Publications
  • Technical Specifications
  • FAQ
  • Careers

Follow Us





Get In Touch

1-888-STRADOS
Info@stradoslabs.com

Stay updated with news and insights!

Success!

Submit

© 2025 Strados Labs®  |  Privacy Policy  |   Cookie Policy